JP2016502843A5 - - Google Patents

Download PDF

Info

Publication number
JP2016502843A5
JP2016502843A5 JP2015547559A JP2015547559A JP2016502843A5 JP 2016502843 A5 JP2016502843 A5 JP 2016502843A5 JP 2015547559 A JP2015547559 A JP 2015547559A JP 2015547559 A JP2015547559 A JP 2015547559A JP 2016502843 A5 JP2016502843 A5 JP 2016502843A5
Authority
JP
Japan
Prior art keywords
bioactive agent
capture
cell
solid surface
target
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2015547559A
Other languages
English (en)
Japanese (ja)
Other versions
JP6484178B2 (ja
JP2016502843A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2013/074756 external-priority patent/WO2014093671A1/en
Publication of JP2016502843A publication Critical patent/JP2016502843A/ja
Publication of JP2016502843A5 publication Critical patent/JP2016502843A5/ja
Application granted granted Critical
Publication of JP6484178B2 publication Critical patent/JP6484178B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2015547559A 2012-12-12 2013-12-12 生物活性剤の細胞標的の捕捉のための組成物および方法 Active JP6484178B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201261736426P 2012-12-12 2012-12-12
US61/736,426 2012-12-12
US201361788313P 2013-03-15 2013-03-15
US61/788,313 2013-03-15
PCT/US2013/074756 WO2014093671A1 (en) 2012-12-12 2013-12-12 Compositions and methods for capture of cellular targets of bioactive agents

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2019025449A Division JP6999589B2 (ja) 2012-12-12 2019-02-15 生物活性剤の細胞標的の捕捉のための組成物および方法

Publications (3)

Publication Number Publication Date
JP2016502843A JP2016502843A (ja) 2016-02-01
JP2016502843A5 true JP2016502843A5 (enExample) 2019-02-07
JP6484178B2 JP6484178B2 (ja) 2019-03-13

Family

ID=50934961

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2015547559A Active JP6484178B2 (ja) 2012-12-12 2013-12-12 生物活性剤の細胞標的の捕捉のための組成物および方法
JP2019025449A Active JP6999589B2 (ja) 2012-12-12 2019-02-15 生物活性剤の細胞標的の捕捉のための組成物および方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2019025449A Active JP6999589B2 (ja) 2012-12-12 2019-02-15 生物活性剤の細胞標的の捕捉のための組成物および方法

Country Status (11)

Country Link
US (2) US9551705B2 (enExample)
EP (1) EP2931305B1 (enExample)
JP (2) JP6484178B2 (enExample)
KR (2) KR102272233B1 (enExample)
CN (1) CN104853767B (enExample)
AU (2) AU2013359160B2 (enExample)
BR (1) BR112015013715A2 (enExample)
CA (1) CA2894432C (enExample)
IL (1) IL239213B (enExample)
SG (1) SG11201504520XA (enExample)
WO (1) WO2014093671A1 (enExample)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4159833A3 (en) 2009-12-09 2023-07-26 The Procter & Gamble Company Fabric and home care products
JP6522339B2 (ja) * 2011-11-21 2019-05-29 プロメガ コーポレイションPromega Corporation カルボキシxローダミン類似体
WO2014093671A1 (en) 2012-12-12 2014-06-19 Promega Corporation Compositions and methods for capture of cellular targets of bioactive agents
JP6604938B2 (ja) 2013-03-15 2019-11-13 プロメガ コーポレイション タンパク質を官能基または固体表面に共有結合的に係留するための基質
US10168323B2 (en) 2013-03-15 2019-01-01 Promega Corporation Compositions and methods for capture of cellular targets of bioactive agents
WO2016196956A1 (en) * 2015-06-05 2016-12-08 Promega Corporation Cell-permeable, cell-compatible, and cleavable linkers for covalent tethering of functional elements
US10458988B2 (en) * 2017-03-03 2019-10-29 Musc Foundation For Research Development Biotinylated luminescent probe
US12181452B2 (en) 2017-09-18 2024-12-31 Waters Technologies Corporation Use of vapor deposition coated flow paths for improved chromatography of metal interacting analytes
US12180581B2 (en) 2017-09-18 2024-12-31 Waters Technologies Corporation Use of vapor deposition coated flow paths for improved chromatography of metal interacting analytes
US11709155B2 (en) 2017-09-18 2023-07-25 Waters Technologies Corporation Use of vapor deposition coated flow paths for improved chromatography of metal interacting analytes
US11709156B2 (en) 2017-09-18 2023-07-25 Waters Technologies Corporation Use of vapor deposition coated flow paths for improved analytical analysis
US11913944B2 (en) 2019-03-20 2024-02-27 Promega Corporation Photoaffinity probes
US11918936B2 (en) 2020-01-17 2024-03-05 Waters Technologies Corporation Performance and dynamic range for oligonucleotide bioanalysis through reduction of non specific binding
CN116391122A (zh) 2020-09-24 2023-07-04 沃特世科技公司 用于反应性分子分离的色谱硬件改进
JP2022182394A (ja) * 2021-05-28 2022-12-08 独立行政法人国立病院機構 抗原固相化デバイス
US20250120928A1 (en) * 2021-07-14 2025-04-17 University Of Maryland, Baltimore Suberoylanilide hydroxamic acid (saha) drugs, conjugates, and nanoparticles, and methods of use thereof

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5914095A (en) 1989-04-07 1999-06-22 Salutar, Inc. Polychelants containg amide bonds
ES2136103T3 (es) 1992-06-22 1999-11-16 Kyowa Hakko Kogyo Kk Procedimiento para la preparacion de derivados de estaurosporina.
US5756688A (en) 1992-10-14 1998-05-26 Sterling Winthrop Inc. MR imaging compositions and methods
HK1001498A1 (en) 1992-10-14 1998-06-19 Nycomed Imaging As Chelating polymers
GB9503969D0 (en) 1995-02-28 1995-04-19 Sams Bernard Incrementing mechanism
WO2001053355A1 (en) * 2000-01-24 2001-07-26 The Trustees Of Columbia University In The City Of New York An in vivo screen using chemical inducers of dimerization
US20020168737A1 (en) 2001-01-24 2002-11-14 Cornish Virginia W. Binding and catalysis screen for high throughput determination of protein function using chemical inducers of dimerization
DK1545613T3 (da) 2002-07-31 2011-11-14 Seattle Genetics Inc Auristatinkonjugater og deres anvendelse til behandling af cancer, en autoimmun sygdom eller en infektiøs sygdom
AU2004211584B2 (en) 2003-01-31 2009-11-12 Promega Corporation Covalent tethering of functional groups to proteins
US7429472B2 (en) 2003-01-31 2008-09-30 Promega Corporation Method of immobilizing a protein or molecule via a mutant dehalogenase that is bound to an immobilized dehalogenase substrate and linked directly or indirectly to the protein or molecule
KR100507796B1 (ko) 2003-04-03 2005-08-17 한미약품 주식회사 생체내 반감기가 증가된 peg-생리활성 폴리펩티드 동종이량체 결합체 및 이의 제조방법
US7425436B2 (en) 2004-07-30 2008-09-16 Promega Corporation Covalent tethering of functional groups to proteins and substrates therefor
EP1989548A2 (en) 2006-02-08 2008-11-12 Promega Corporation Compositions and methods for capturing and analyzing cross-linked biomolecules
JP5420198B2 (ja) * 2008-06-16 2014-02-19 オリンパス株式会社 タンパク質相互作用解析方法、ポリヌクレオチド、および、組成物
KR100891456B1 (ko) 2008-11-06 2009-04-01 씨지케이 주식회사 생리활성물질에 대한 세포내 표적물질을 검출하는 방법 및 장치
PL2456864T3 (pl) * 2009-05-01 2016-04-29 Promega Corp Syntetyczna lucyferaza z oplophorus o wzmocnionej emisji światła
US8669103B2 (en) 2010-11-02 2014-03-11 Promega Corporation Oplophorus-derived luciferases, novel coelenterazine substrates, and methods of use
WO2014093671A1 (en) 2012-12-12 2014-06-19 Promega Corporation Compositions and methods for capture of cellular targets of bioactive agents
JP6604938B2 (ja) * 2013-03-15 2019-11-13 プロメガ コーポレイション タンパク質を官能基または固体表面に共有結合的に係留するための基質
US10168323B2 (en) * 2013-03-15 2019-01-01 Promega Corporation Compositions and methods for capture of cellular targets of bioactive agents
WO2016196956A1 (en) * 2015-06-05 2016-12-08 Promega Corporation Cell-permeable, cell-compatible, and cleavable linkers for covalent tethering of functional elements

Similar Documents

Publication Publication Date Title
JP2016502843A5 (enExample)
Skaug et al. Intermittent molecular hopping at the solid-liquid interface
US20050239068A1 (en) Method for isolating nucleic acids and protein from a single sample
WO2017085172A3 (en) Improved serum albumin binders
JP2013255517A5 (enExample)
JP2007503831A5 (enExample)
JP2017536114A5 (enExample)
JP2012228272A5 (enExample)
JP2014012025A5 (enExample)
WO2016100976A3 (en) Methods for identifying multiple epitopes in selected sub-populations of cells
WO2011123246A3 (en) Solid-phase clonal amplification and related methods
WO2011073214A3 (en) A method for identifying hetero-multimeric modified ubiquitin proteins with binding capability to ligands
WO2014106004A3 (en) High-throughput system and method for identifying antibodies having specific antigen binding activities
Podgornik et al. Application of monoliths for bioparticle isolation
WO2020131182A3 (en) Compounds, compositions, and methods for improving assays
JP2014528696A5 (enExample)
JP2017536846A5 (enExample)
JP2017514481A5 (enExample)
WO2012091564A3 (en) A cross linking polypeptide comprising an hexameric single chain antibody binding mhc-mage complex that induces apoptosis
JP2015518489A5 (enExample)
HRP20220093T1 (hr) Platforme za provjeravanje kemijski kodiranih prostorno adresiranih biblioteka
WO2016048994A3 (en) Systems and methods of cell-free protein synthesis in droplets and other compartments
JP2016513643A5 (enExample)
Zeng et al. Efficient enrichment of phosphopeptides by magnetic TiO2‐coated carbon‐encapsulated iron nanoparticles
JP2011004734A5 (enExample)